Gary Miller

Biography
Dr. Miller is a leader in the field of exposomics, which studies the comprehensive and cumulative effects of physical, chemical, biological, and social factors that influence biology and health. His laboratory uses mass spectrometry-based exposomics to study environmental drivers of Parkinson’s disease, Alzheimer’s disease, cognitive decline, diabetes, and cancer. He founded the first exposome-based center in the U.S. and has been funded by multiple agencies, including NIH, DOD, and ARPA-H. Dr. Miller is a Fellow of the American Association for the Advancement of Science and serves on the advisory panel of the National Institutes of Health All of Us Research Program. In 2026, he was named the International Collen-Francqui Chair in Belgium, where he gave a series of lectures and facilitated research collaborations at Ghent University, Antwerp University, University of Liège, KU Leuven, and Hasselt University. He has also served as a Visiting Professor at the University of Paris.

---

Talk
The exposome: environmental precision medicine
Using exposomics, it is now possible to measure environmental chemicals, medications, and endogenous small molecules at the same time, enabling exposome-wide analysis of any human condition. Dr. Miller will discuss how his team is using exposomics to better understand the cause, progression, and treatment of a range of diseases.